Basiliximab (Simulect): simplifying induction therapy.
Bell
J
J
Samaritan Transplant Services, Phoenix, AZ, USA.
Colaneri
J
J
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000077552:Basiliximab; D004347:Drug Interactions; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D024802:Nurse's Role; D018579:Patient Selection; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use*; D006435:Renal Dialysis; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab